At a time when the world is contending with a hitherto unseen and unknown foe in the novel coronavirus, you might wonder why a vaccine for malaria is making news. The RTS,S/AS01 vaccine, which has the brand name Mosquirix, has been developed by the UK-based pharma major GSK to act against Plasmodium falciparum, “the deadliest malaria parasite globally and the …
